Literature DB >> 6226193

Prevalence and natural history of electrocardiographic left ventricular hypertrophy.

W B Kannel.   

Abstract

Left ventricular hypertrophy, particularly on the electrocardiogram, is an ominous, not an incidental accompaniment of hypertension and cardiovascular disease. The prevalence of electrocardiographic left ventricular hypertrophy increases with age with a slight male predominance, and one in 10 persons aged 30 to 62 can expect to have it within 12 years. At any age, cardiac enlargement on roentgenograms is twice as prevalent as electrocardiographic left ventricular hypertrophy, and in only 16 percent of those with x-ray evidence of cardiac enlargement does electrocardiographic left ventricular hypertrophy subsequently develop. Hypertension predisposes and at systolic pressures exceeding 180 mm Hg evidence of electrocardiographic left ventricular hypertrophy develops in 50 percent, with no closer relation to diastolic, than to systolic pressure. In addition to drastic curtailment of life expectancy, electrocardiographic left ventricular hypertrophy is a harbinger of serious cardiovascular disease. Definite electrocardiographic left ventricular hypertrophy is associated with an eightfold increase in cardiovascular mortality and a sixfold increase in coronary mortality. Electrocardiographic left ventricular hypertrophy with repolarization criteria more than doubles the risk of hypertension alone and carries a greater risk of cardiovascular morbidity and mortality than cardiac enlargement. It identifies hypertensive patients with a compromised coronary circulation and myocardial damage. Risk of stroke, cardiac failure, and every clinical manifestation of coronary heart disease is substantially increased. In those with electrocardiographic left ventricular hypertrophy risk of cardiac failure is three times that in those with hypertension alone. Electrocardiographic left ventricular hypertrophy based solely on voltage criteria reflects chiefly the severity and duration of associated hypertension, carrying only half the cardiovascular risk of electrocardiographic left ventricular hypertrophy with repolarization abnormality. The precise pathologic and anatomic meaning of electrocardiographic left ventricular hypertrophy is unclear in view of the modest correlations with anatomic, x-ray, ventriculographic, and electrocardiographic measures of cardiac hypertrophy. The electrocardiographic aberrations are as much a product of myocardial damage as hypertrophy, and their appearance must be regarded as a grave prognostic sign in the course of cardiovascular disease.

Entities:  

Mesh:

Year:  1983        PMID: 6226193     DOI: 10.1016/0002-9343(83)90111-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  52 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.

Authors:  E Foster; J F Plehn; S A Bernard; N J Battinelli; M Huntington-Coats; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

Review 3.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 4.  Hypertension in non-insulin dependent diabetes mellitus and its management.

Authors:  M D Feher
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 5.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

6.  Confounding in epidemiological studies: why "independent" effects may not be all they seem.

Authors:  G D Smith; A N Phillips
Journal:  BMJ       Date:  1992-09-26

Review 7.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

8.  Relationship of electrocardiographic left ventricular hypertrophy to the presence of diastolic dysfunction.

Authors:  Joseph M Krepp; Fay Lin; James K Min; Richard B Devereux; Peter M Okin
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-17       Impact factor: 1.468

Review 9.  [Standard-ECG].

Authors:  Bernd-Dieter Gonska
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-09

10.  Diagnostic accuracy of left ventricular hypertrophy in patients with myocardial infarction by computer-assisted electrocardiography (ELECTROPRES).

Authors:  Luis Rodríguez-Padial; Finn Akerström; Carolina Robles-Gamboa; Josep Andrés; Jessica Ruiz-Baena
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.